Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- In obesity, growing CV risk burden demands cross-specialty collaboration, new solutions
-
- Anti-aging mechanism may hold key to ‘perfect’ osteoporosis treatment
- FDA approves interoperable insulin pump under new regulatory pathway
- NIH funding first artificial pancreas study in pregnant women
- Children’s adherence to GH therapy ‘suboptimal’
- Coverage for pediatric GH therapy varies widely in idiopathic short stature
- Early thyroidectomy can improve survival in multiple endocrine neoplasia type 2B
- Estradiol level influences fracture risk during menopause transition
- Exenatide enhances in-hospital glycemic control
-
- Extreme insulin resistance influences thyroid nodule growth in children
- Few adults with prediabetes referred to, participating in diabetes prevention programs
- Hypertension speeds diabetes progression, increases CVD risk
- Low odds for full recovery from hip fracture found among older adults
- Most children, adults not meeting ADA goals for type 1 diabetes management
- No link between Hashimoto’s thyroiditis, thyroid cancer in children
- PCOS may increase overall cancer risk
- Secondary osteoporosis, rheumatoid arthritis improve FRAX accuracy in multiple sclerosis
-
- Switch from analogue to human insulin safe, cost-effective in older adults with type 2 diabetes
- Type 1 diabetes status not associated with reading, math scores in children
- Untreated hyperthyroidism increases CVD risk
- Vegan meals increase satiety in type 2 diabetes, obesity
- Is the gut or the brain more important in regulating appetite and metabolism?